Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO | |
Zhang, Anle; Zheng, Yuanhong; Que, Zujun; Zhang, Lingling; Lin, Shengchao; Vanminh Le; Liu, Jianwen; Tian, Jianhui | |
刊名 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
![]() |
2014 | |
卷号 | 140期号:11 |
关键词 | IDO AS-IV Immunotherapy Regulatory T cells Cytotoxic T lymphocytes |
ISSN号 | 0171-5216 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3657610 |
专题 | 上海中医药大学 |
推荐引用方式 GB/T 7714 | Zhang, Anle,Zheng, Yuanhong,Que, Zujun,et al. Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO[J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY,2014,140(11). |
APA | Zhang, Anle.,Zheng, Yuanhong.,Que, Zujun.,Zhang, Lingling.,Lin, Shengchao.,...&Tian, Jianhui.(2014).Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO.JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY,140(11). |
MLA | Zhang, Anle,et al."Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO".JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 140.11(2014). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论